Priority guide

BPH treatment and sexual function: separate ejaculation from erection

A treatment can preserve erections and still cause dry ejaculation. Good counseling names the exact function at risk before the procedure is chosen.

Evidence reviewed August 14, 2026Clinical review pending; evidence sources are shown

“Will this affect sex?” is too broad to answer well. Erectile rigidity, libido, orgasm, ejaculate volume, forward versus retrograde ejaculation, pain, fertility, and partner experience are different outcomes.

Most BPH procedures have a larger and more predictable effect on ejaculation than on erections. That distinction is central to shared decision-making and often changes which option a patient prefers.

Erection

Most contemporary BPH procedures preserve erectile function for most men, but no procedure has zero risk. Baseline vascular disease, diabetes, age, medications, anesthesia, pelvic pain, complications, and recovery can all influence erections.

Daily tadalafil may improve both erectile and urinary symptoms in selected men. Procedures that preserve ejaculation are not automatically more effective for erections.

Ejaculation and orgasm

TURP, GreenLight PVP, standard HoLEP, and simple prostatectomy commonly cause dry or retrograde ejaculation. Orgasm may still occur, but semen does not travel forward in the usual way. The sensation can be similar, reduced, or simply different.

PUL, WVTT, iTind, Optilume, PAE, and Aquablation are generally chosen partly because antegrade ejaculation is preserved more often. Preservation is not guaranteed, and the quality of evidence differs substantially among them.

Fertility

Dry or retrograde ejaculation can impair natural conception even when erections and orgasm remain intact. Men who may want biological children should discuss sperm banking or fertility consultation before a treatment with a high ejaculatory-impact probability.

Paclitaxel-coated technology has labeling-specific reproductive precautions. These should be reviewed directly with the current device instructions rather than inferred from general BPH counseling.

Questions that produce useful counseling

  • What percentage of your own patients retain forward ejaculation after this exact technique?
  • Do you define preservation as any fluid, normal volume, or patient-reported unchanged function?
  • Could a modified ejaculatory-sparing technique reduce durability?
  • How do my middle lobe, gland size, and bladder-neck treatment change the estimate?
  • What are my options if ejaculation or erections change after treatment?

Bottom line

Document baseline function, identify which sexual outcome matters, and compare procedure-specific probabilities—not a vague promise that “sexual function is preserved.”

Evidence trail

Sources and evidence

Open the original guideline, regulatory record, or study. Evidence was last checked August 14, 2026.

  1. AUA Guideline (2026) Part II: Medical Management The Journal of Urology · professional guideline · 2026
  2. AUA Guideline (2026) Part III: Procedural/Surgical Management The Journal of Urology · professional guideline · 2026
  3. Disease Management — Management of Non-neurogenic Male LUTS European Association of Urology · professional guideline · 2026